Crossmark

Diagnostic Value and Short-Term Prognosis Assessment of Copeptin in Non-ST-Elevation Acute Coronary Syndrome

Published Online: 2024-12-28

Published Print: 2025-04

Authors

Cui, Facai https://orcid.org/0009-0005-7858-6456
Pei, Xueliang

Ling, Mingzhi

Guo, Fengxia
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82002199)
License Information

Text and Data Mining valid from 2024-12-28

Version of Record valid from 2024-12-28
More Information

Article History

Received: 17 August 2024

Accepted: 17 December 2024

First Online: 28 December 2024

Declarations

:

: The experiments were approved by the Ethics Committee of Henan Provincial People's Hospital (approval number: 2023042). All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and the Helsinki Declaration. Informed consent was obtained from all patients for inclusion in the study.

: No animal studies were carried out by the authors for this article.

: Not applicable.

: The authors declare no competing interests.

Document is current